HCA Healthcare stock reports 8.7 percent revenue growth

HCA Healthcare stock was trading at USD 436.48 on the NYSE on September 23, 2026, while the company reported USD 20.23 billion in second-quarter revenue, up 8.7 percent year over year. The latest figures show revenue expansion alongside a share price 21.57 percent below its 52-week high of USD 556.52.

Revenue reaches USD 20.23 billion

HCA Healthcare released its second-quarter results on July 24, 2026. According to MarketBeat, revenue reached USD 20.23 billion, compared with analyst expectations of USD 19.76 billion. That put reported revenue USD 470 million above consensus and lifted the year-over-year growth rate to 8.7 percent.

The earnings comparison was also positive. Adjusted EPS came in at USD 7.59 against consensus of USD 7.56, while the prior-year quarter produced USD 6.84 per share, according to MarketBeat. The figures point to continued earnings growth even as the valuation remains below the yearly peak.

Dividend adds a dated checkpoint

HCA Healthcare also declared a quarterly dividend of USD 0.78 per share. The payment is scheduled for September 30, 2026, for shareholders of record on September 16, 2026, according to MarketBeat. The annualized dividend is USD 3.12 per share, giving investors a concrete income reference alongside the quarterly earnings figures.

For investors, the central contrast is clear in the numbers. Revenue exceeded consensus by USD 470 million, but the September 23 share price remained USD 120.04 below the 52-week high, leaving operating performance and market valuation on different paths.

Stock remains below yearly high

HCA Healthcare stock was trading at USD 436.48 on September 23, 2026, on the NYSE, with a market capitalization of USD 94,498,575,593. The 52-week range was USD 353.99 to USD 556.52, placing the reference price 23.31 percent above the low and 21.57 percent below the high.